课题基金 / 基金详情

Developing the world's first baby-milk free from carcinogenic and genotoxic tropical oils

Developing the world's first baby-milk free from carcinogenic and genotoxic tropical oils
开发世界上第一个不含致癌和基因毒性热带油的婴儿奶粉
批准号:
10067259
负责人:
金额:
$21.1万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
肯达尔Nutricare(KNC)是一家快速增长的英国家族企业,曾获得皇后奖,目前正寻求通过开发一种世界首创的婴儿奶粉创新来颠覆每年400亿美元的全球婴儿配方奶粉市场,这种婴儿奶粉将更安全,营养更优越,更自然,更可持续,科学上更接近母乳的黄金标准。Kendamil-Bio(代号“Kendamil-Bio”)将代表一种根本性的创新配方,在该行业150年的历史中,从未尝试过用新型天然成分取代含有有害毒素的已知成分,从而提高婴儿安全性,营养质量,接近母乳和产品可持续性。该项目将利用KNC团队500多年来在婴儿营养创新方面积累的专业知识,为婴儿提供世界上营养最全面、环境最可持续的婴儿奶粉,通过整合与儿童认知发展和增强免疫力相关的几种母乳成分,Kendamil-Bio原型的开发是世界上第一个在英国制造的产品,将包括一个为期18个月的项目,涉及24名KNC团队成员,包括研发技术人员,食品科学家,质量保证专业人员、生产工程师和高级管理人员,在KNC位于联合国教科文组织世界遗产英国湖区门户肯达尔的世界级、BRC AA级、FDA注册的生产设施中进行。成功开发出一种新颖、更安全、营养优越、更环保的婴儿奶粉,预计将带来可观的出口收入,我们的目标是为英国农业和当地熟练就业机会提供再投资,同时向全球配方奶粉行业展示我们在英国的世界级能力所能实现的更有效、安全、道德和可持续的制造标准。
英文摘要
Kendal Nutricare (KNC), a rapid-growth and Queens Award winning British family business, is seeking to disrupt the $40-billion per-year global infant-formula market by developing a world-first innovation in baby milk that will be safer, nutritionally-superior, more naturally and sustainably-made and scientifically closer to the gold-standard of breastmilk.The prototype recipe (code-name 'Kendamil-Bio'), will be represent a fundamentally innovative formulation, not before attempted in the industry's 150-year history, to replace known ingredients containing harmful toxins with novel, natural ingredients that enhance infant-safety, nutritional-quality, proximity to breastmilk and prouct sustainability. This project will leverage KNC teams' 500+ years' cumulative expertise in infant nutrition innovation to provide infants the most nutritionally-complete, environmentally-sustainable baby-milk in the world, one designed to be uniquely closer to human-milk by incorporating several breastmilk components linked to cognitive development and strengthened immunity in children, at levels never before reached in infant formulations.Development of the Kendamil-Bio prototype, a world-first product made here in the UK, will comprise an 18 month project involving 24 KNC team members including R&D technicians, food scientists, quality assurance professionals, production engineers and senior management, carried out at KNC's world-class, BRC AA-grade, FDA-registered production facilities in Kendal, gateway to the English Lake District, a UNESCO World Heritage Site.Successful development of a novel, safer, nutritionally-superior and more environmentally-sustainable baby-milk is estimated to deliver material export revenue, re-investment in British agriculture and local skilled employment opportunities, while showcasing to the global formula industry a more effective, secure, ethical and sustainable standard of manufacturing that can be achieved, led by our world-class capabilities here in the UK.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
国际心脏研究会第二十三届世界大会(XXIII World Congress ISHR)
  • 批准号:
    81942001
  • 项目类别:
    专项基金项目
  • 资助金额:
    10万元
  • 批准年份:
    2019
  • 负责人:
    朱毅
  • 依托单位:
相对论中的薄球壳模型及其在宇宙论中的应用
  • 批准号:
    10605006
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2006
  • 负责人:
    高思杰
  • 依托单位:
利用结构特性分析和控制动态布尔网络
  • 批准号:
    60574067
  • 项目类别:
    面上项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2005
  • 负责人:
    赵千川
  • 依托单位:
探讨复杂动力网络的同步能力和鲁棒性